Literature DB >> 23450970

Oncology and the Internet: regulatory failure and reform.

Tim K Mackey1, Bryan A Liang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23450970      PMCID： PMC3500477          DOI： 10.1200/JOP.2012.000579

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN： 1554-7477            Impact factor:   3.840


× No keyword cloud information.
  13 in total

1.  The shortage of essential chemotherapy drugs in the United States.

Authors:  Mandy L Gatesman; Thomas J Smith
Journal:  N Engl J Med       Date:  2011-10-31       Impact factor: 91.245

2.  The drug shortage crisis in the United States: causes, impact, and management strategies.

Authors:  C Lee Ventola
Journal:  P T       Date:  2011-11

3.  The global counterfeit drug trade: patient safety and public health risks.

Authors:  Tim K Mackey; Bryan A Liang
Journal:  J Pharm Sci       Date:  2011-06-22       Impact factor: 3.534

4.  Shortages of cancer drugs in the USA.

Authors: 
Journal:  Lancet Oncol       Date:  2011-04       Impact factor: 41.316

5.  Medicine. Shortages of cancer drugs put patients, trials at risk.

Authors:  Jocelyn Kaiser
Journal:  Science       Date:  2011-04-29       Impact factor: 47.728

Review 6.  Risks of online direct-to-consumer tumor markers for cancer screening.

Authors:  Kimberly M Lovett; Bryan A Liang; Timothy K Mackey
Journal:  J Clin Oncol       Date:  2012-02-21       Impact factor: 44.544

7.  Searching for safety: addressing search engine, website, and provider accountability for illicit online drug sales.

Authors:  Bryan A Liang; Tim Mackey
Journal:  Am J Law Med       Date:  2009

8.  Prevalence and Global Health implications of social media in direct-to-consumer drug advertising.

Authors:  Bryan A Liang; Timothy K Mackey
Journal:  J Med Internet Res       Date:  2011-08-31       Impact factor: 5.428

Review 9.  Quality of online pharmacies and websites selling prescription drugs: a systematic review.

Authors:  Grazia Orizio; Anna Merla; Peter J Schulz; Umberto Gelatti
Journal:  J Med Internet Res       Date:  2011-09-30       Impact factor: 5.428

10.  Online availability and safety of drugs in shortage: a descriptive study of internet vendor characteristics.

Authors:  Bryan A Liang; Tim K Mackey
Journal:  J Med Internet Res       Date:  2012-02-09       Impact factor: 5.428
View more
  7 in total

Review 1.  After counterfeit Avastin®--what have we learned and what can be done?

Authors:  Tim K Mackey; Raphael Cuomo; Camille Guerra; Bryan A Liang
Journal:  Nat Rev Clin Oncol       Date:  2015-03-03       Impact factor: 66.675

2.  Counterfeit drug penetration into global legitimate medicine supply chains: a global assessment.

Authors:  Tim K Mackey; Bryan A Liang; Peter York; Thomas Kubic
Journal:  Am J Trop Med Hyg       Date:  2015-04-20       Impact factor: 2.345

3.  An exploration of counterfeit medicine surveillance strategies guided by geospatial analysis: lessons learned from counterfeit Avastin detection in the US drug supply chain.

Authors:  Raphael E Cuomo; Tim K Mackey
Journal:  BMJ Open       Date:  2014-12-02       Impact factor: 2.692

4.  A challenge for healthcare but just another opportunity for illegitimate online sellers: Dubious market of shortage oncology drugs.

Authors:  András Fittler; Róbert György Vida; Valter Rádics; Lajos Botz
Journal:  PLoS One       Date:  2018-08-28       Impact factor: 3.240

5.  Global reach of direct-to-consumer advertising using social media for illicit online drug sales.

Authors:  Tim Ken Mackey; Bryan A Liang
Journal:  J Med Internet Res       Date:  2013-05-29       Impact factor: 5.428

6.  Pharmaceutical digital marketing and governance: illicit actors and challenges to global patient safety and public health.

Authors:  Tim K Mackey; Bryan A Liang
Journal:  Global Health       Date:  2013-10-16       Impact factor: 4.185

7.  Improving global health governance to combat counterfeit medicines: a proposal for a UNODC-WHO-Interpol trilateral mechanism.

Authors:  Tim K Mackey; Bryan A Liang
Journal:  BMC Med       Date:  2013-10-31       Impact factor: 8.775
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.